InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Hausman Diana. Officer active across 2 companies, notably Zentalis Pharmaceuticals, Inc.. Cumulatively, 4 disclosures have been published. Split: 1 buy · 1 sell. Total volume traded: €47k. Activity tracked since 8 May 2023. The latest transaction was disclosed on 2 July 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
HAUSMAN DIANA is Chief Medical Officer at Zentalis Pharmaceuticals, Inc. and Director at Immuneering Corp. She has 4 filings in total, and across the 4 recent filings available, the aggregated amounts are EUR 7618 in buys and EUR 39269 in sells, from 2023-05-10 to 2025-07-07. The modal transaction nature is Attribution.